Philadelphia’s Biotech Powerhouse: The City Fueling the United States of America’s Next Medical Breakthroughs

Philadelphia has long been known as a hub for history, education, and culture. But in recent years, the city has also solidified itself as a powerhouse i...

February 20, 2025 | Thursday | Reports
Merck KGaA Ushers in New Leadership Era with Key Executive Appointments

Appointment of three internal senior executives ensures strategic continuity with a new era of leadership Jean-Charles Wirth to become CEO Life Scienc...

February 18, 2025 | Tuesday | News
Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans

Artificial intelligence is reshaping oncology, and ImpriMed is at the forefront of this transformation. With its AI-powered Personalized Prediction Profi...

February 18, 2025 | Tuesday | Interview
AstraZeneca CEO Pascal Soriot Leads Strong FY 2024 Growth with 21% Revenue Surge and Ambition 2030 in Focus

AstraZeneca delivered $54.1 billion in total revenue for FY 2024, a 21% increase at constant exchange rates (CER), fueled by strong growth across oncolog...

February 07, 2025 | Friday | Company results
Intuitive BioTechnologies Expands Elemental Analysis Services in North America

Intuitive BioTechnologies LLC (IBT) is proud to announce they have added elemental analysis to their testing capabilities. IBT is now offering quantitati...

February 07, 2025 | Friday | News
Illumina’s CEO Jacob Thaysen Drives Strategic Growth as Q4 Revenue Surpasses Expectations

      Illumina, led by CEO Jacob Thaysen, delivered a Q4 revenue of $1.1 billion, reflecting a steady 1% year-over-year increase, w...

February 07, 2025 | Friday | Company results
BD Reports Strong Q1 2025 Results with $5.2B Revenue as CEO Tom Polen Announces Strategic Business Separation

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company,  announced its financial results for the first quarter ...

February 06, 2025 | Thursday | Company results
BioMed X and Merck Reveal Critical Insights on Extrachromosomal DNA in Cancer Paving the Way for Novel Therapies

The research of BioMed X team EDC - Extrachromosomal DNA in Cancer - has uncovered critical insights into the mechanisms driving extrachromosomal ...

February 06, 2025 | Thursday | News
Albert Bourla Leads Pfizer to $63.6B Triumph in 2024 – Record Growth, Bold Strategy, and a Sharpened Vision for 2025!

Pfizer Inc. reported robust financial results for the full year 2024, achieving total revenues of $63.6 billion, reflecting a 7% year-over-year operation...

February 04, 2025 | Tuesday | Company results
Novartis Posts 12% Sales Growth in 2024 as CEO Vas Narasimhan Sets Sights on Stronger 2025

Net sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance from Ent...

January 31, 2025 | Friday | Company results
Marc N. Casper on Thermo Fisher's Strong 2024 Finish: "We Drove Meaningful Growth, Positioned for Excellence in 2025

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year...

January 30, 2025 | Thursday | Company results
Labviva CEO Siamak Baharloo on Transforming Life Sciences Procurement with Innovation and AI

In a conversation with BioPharma BoardRoom, Siamak Baharloo, the visionary Co-founder and CEO of Labviva, delves into the transformative role of technology...

January 22, 2025 | Wednesday | Interview
Beckman Coulter Life Sciences and Indiana University Secure $2.5M Grant to Boost Leukemia and Lymphoma Testing in Kenya

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been a...

January 22, 2025 | Wednesday | News
Pioneer Group Partners with Thermo Fisher to Empower Biotech Startups in Healthcare and Sustainability

Pioneer Group has  announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commerci...

January 16, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close